IL78576A0 - 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same - Google Patents

5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same

Info

Publication number
IL78576A0
IL78576A0 IL78576A IL7857686A IL78576A0 IL 78576 A0 IL78576 A0 IL 78576A0 IL 78576 A IL78576 A IL 78576A IL 7857686 A IL7857686 A IL 7857686A IL 78576 A0 IL78576 A0 IL 78576A0
Authority
IL
Israel
Prior art keywords
pyrimidinecarboxamide
processes
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL78576A
Other languages
English (en)
Original Assignee
Uniroyal Chem Co Inc
Uniroyal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chem Co Inc, Uniroyal Ltd filed Critical Uniroyal Chem Co Inc
Publication of IL78576A0 publication Critical patent/IL78576A0/xx
Priority to IL8886711A priority Critical patent/IL86711A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL78576A 1985-04-22 1986-04-22 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same IL78576A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL8886711A IL86711A0 (en) 1985-04-22 1988-06-12 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/725,736 US4636508A (en) 1985-04-22 1985-04-22 5-pyrimidinecarboxyamides and treatment of leukemia therewith

Publications (1)

Publication Number Publication Date
IL78576A0 true IL78576A0 (en) 1986-08-31

Family

ID=24915762

Family Applications (2)

Application Number Title Priority Date Filing Date
IL78576A IL78576A0 (en) 1985-04-22 1986-04-22 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same
IL8886711A IL86711A0 (en) 1985-04-22 1988-06-12 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL8886711A IL86711A0 (en) 1985-04-22 1988-06-12 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US4636508A (fr)
JP (1) JPS6259264A (fr)
CN (2) CN1014990B (fr)
AT (1) AT391864B (fr)
AU (3) AU592559B2 (fr)
BE (1) BE904641A (fr)
CA (1) CA1274509A (fr)
CH (1) CH668970A5 (fr)
DE (1) DE3613447A1 (fr)
DK (1) DK182986A (fr)
ES (3) ES8800671A1 (fr)
FR (1) FR2580642B1 (fr)
GB (1) GB2174391B (fr)
GR (1) GR861024B (fr)
IL (2) IL78576A0 (fr)
IT (1) IT1214499B (fr)
LU (1) LU86403A1 (fr)
NL (1) NL8601023A (fr)
NZ (1) NZ215874A (fr)
SE (1) SE8601826L (fr)
ZA (1) ZA862630B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
FR2628741A1 (fr) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd Nouveaux composes n-phenyl-5-pyrimidinecarboxamides et composition pharmaceutique les contenant utilisable pour induire la regression de la leucemie ou des tumeurs
FR2628869A1 (fr) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd
EP0430885A3 (en) * 1989-12-01 1991-11-06 Ciba-Geigy Ag Anthelmintical compounds
AU2002334205B2 (en) * 2001-10-26 2007-07-05 Istituto Di Ricerche Di Biologia Molecolara P. Angeletti Spa Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
US9428466B2 (en) * 2013-11-13 2016-08-30 Raymond P. Warrell, Jr. Methods for reducing uric acid levels using barbiturate derivatives
WO2015123003A1 (fr) * 2014-02-14 2015-08-20 Warrell Raymond P Composés bifonctionnels et leur utilisation pour réduire les taux d'acide urique
US10093658B2 (en) 2015-01-22 2018-10-09 Acquist Llc Bifunctional compounds and use for reducing uric acid levels
TWI771303B (zh) 2016-06-30 2022-07-21 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(一)
WO2018009615A1 (fr) 2016-07-06 2018-01-11 Acquist Llc Composés et utilisation de ces derniers pour réduire les niveaux d'acide urique
WO2018200571A1 (fr) 2017-04-25 2018-11-01 Arbutus Biopharma Corporation Analogues de 2,3-dihydro-1h-indène substitués et leurs méthodes d'utilisation
US12083118B2 (en) 2018-03-29 2024-09-10 Arbutus Biopharma Corporation Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670756A1 (de) * 1966-10-05 1970-12-23 Hoechst Ag Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
NZ183999A (en) * 1976-05-06 1978-09-20 Ciba Geigy Ag 5-phenylcarbamoyl-barbituric acid derivatives and insecticidal agents
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
JPS5625166A (en) * 1979-08-09 1981-03-10 Banyu Pharmaceut Co Ltd 5-fluorouracil derivative
JPS5843960A (ja) * 1981-09-10 1983-03-14 Shoichiro Ozaki 5−フルオロウラシル誘導体,その製造法および制ガン剤
DE3347795A1 (de) * 1983-01-14 1985-08-01 Ozaki, Shoichiro, Ehime Neue 1-(n-substituierte carbamoyl)-5-fluorouracil-derivate und krebshemmende mittel, in denen sie als aktive bestandteile enthalten sind
JPS6012322A (ja) * 1983-07-01 1985-01-22 Toyota Motor Corp 四リンク型サスペンシヨン
IL73840A (en) * 1983-12-19 1988-11-15 Uniroyal Chem Co Inc 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES557683A0 (es) 1987-12-16
ES554245A0 (es) 1987-11-16
ES8801219A1 (es) 1987-12-16
AU5641886A (en) 1986-10-30
FR2580642A1 (fr) 1986-10-24
DK182986D0 (da) 1986-04-21
FR2580642B1 (fr) 1988-12-30
NL8601023A (nl) 1986-11-17
SE8601826L (sv) 1986-10-23
CN1038450A (zh) 1990-01-03
ES8801220A1 (es) 1988-01-01
JPS6259264A (ja) 1987-03-14
ZA862630B (en) 1986-11-26
CN1014990B (zh) 1991-12-04
ATA101986A (de) 1990-06-15
GR861024B (en) 1986-08-14
GB2174391A (en) 1986-11-05
GB2174391B (en) 1988-12-29
DE3613447A1 (de) 1986-10-30
GB8609244D0 (en) 1986-05-21
AT391864B (de) 1990-12-10
SE8601826D0 (sv) 1986-04-21
IT8620153A0 (it) 1986-04-18
AU2219588A (en) 1989-01-05
US4636508A (en) 1987-01-13
LU86403A1 (fr) 1987-12-07
BE904641A (fr) 1986-10-21
DE3613447C2 (fr) 1991-04-11
ES557684A0 (es) 1988-01-01
CA1274509A (fr) 1990-09-25
IT1214499B (it) 1990-01-18
CN86102767A (zh) 1987-01-07
CH668970A5 (de) 1989-02-15
ES8800671A1 (es) 1987-11-16
IL86711A0 (en) 1988-11-30
AU592559B2 (en) 1990-01-18
AU2219688A (en) 1989-01-05
DK182986A (da) 1986-10-23
NZ215874A (en) 1988-09-29

Similar Documents

Publication Publication Date Title
IL75400A0 (en) Dialkoxypyridines,processes for the preparation thereof and pharmaceutical compositions containing the same
IL75120A0 (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
ZA859756B (en) Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same
IL76591A0 (en) Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
LTIP1467A (en) Tertiary hydroxyalkylxantines, process for the preparation thereof and pharmaceutical composition containing them
IL77762A (en) 11beta-phenyl gonane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL78079A0 (en) Sulphonylaminoethyl compounds,their preparation and pharmaceutical compositions containing them
IL79323A (en) Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
HK18194A (en) Substituted benzamide derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
NZ218089A (en) 7-piperazinyl, 4-oxoquinolines and pharmaceutical compositions
IL72085A0 (en) 13alpha-alkylylgonanes,processes for their preparation and pharmaceutical compositions containing the same
EP0157346A3 (en) Quinolizinone compound, processes for preparation thereof and pharmaceutical composition comprising the same
IL80160A (en) Beta-lactam derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL84589A0 (en) Pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
IL80669A0 (en) Cephem compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
IL84913A0 (en) Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
NZ217123A (en) 7-alpha-cephalosporins, pharmaceutical compositions and intermediate compounds
IL78576A0 (en) 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
IL79039A0 (en) 4-oxoquinolinesulfonamides,their preparation and pharmaceutical compositions containing them
IL87563A0 (en) Isoxazole-beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB2179347B (en) Methylenedioxyphenanthrene and -stilbene derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
ZA864487B (en) Anti-thorombosis agent based on glycosaminagolycan,process for its preparation,and pharmaceutical compositions
GB2184726B (en) Azoniaspironortropanol esters, processes for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void